Advisor Group’s Intersect ENT, Inc XENT Stock Holding History

Advisor Group’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$12K	Hold	491	–	–	﹤0.01%	4269
2019 Q3	$8K	Buy	491 +134	+38%	+$2.44K	﹤0.01%	4477
2019 Q2	$8K	Sell	357 -198	-36%	-$5.34K	﹤0.01%	4500
2019 Q1	$18K	Sell	555 -3	-0.5%	-$93	﹤0.01%	4047
2018 Q4	$15K	Buy	558 +97	+21%	+$2.84K	﹤0.01%	4003
2018 Q3	$13K	Buy	461 +104	+29%	+$3.12K	﹤0.01%	4147
2018 Q2	$13K	Hold	357	–	–	﹤0.01%	3960
2018 Q1	$14K	Hold	357	–	–	﹤0.01%	3900
2017 Q4	$12K	Hold	357	–	–	﹤0.01%	4008
2017 Q3	$11K	Hold	357	–	–	﹤0.01%	3932
2017 Q2	$10K	Sell	357 -18	-5%	-$408	﹤0.01%	3947
2017 Q1	$6K	Buy	375 +18	+5%	+$252	﹤0.01%	4062
2016 Q4	$4K	Sell	357 -56	-14%	-$725	﹤0.01%	4058
2016 Q3	$7K	Buy	413 +56	+16%	+$843	﹤0.01%	3773
2016 Q2	$4K	Buy	+357	New	+$5.59K	﹤0.01%	3909

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Advisor Group's XENT Position: Q4 2019 in Review

Advisor Group held its Intersect ENT, Inc (XENT) position steady in Q4 2019 at 491 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #4269.

Advisor Group first reported a position in XENT in Q2 2016 and has held it in 15 quarters since. The position peaked at $18K in Q1 2019. 120 funds tracked by Wall St. Rank hold XENT as of Q4 2019.

Advisor Group held 491 shares of Intersect ENT, Inc worth $12K as of Q4 2019.
Advisor Group left its Intersect ENT, Inc share count unchanged in Q4 2019.
Intersect ENT, Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4269 holding.
Advisor Group first reported a position in Intersect ENT, Inc in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Intersect ENT, Inc position peaked at $18K in Q1 2019.
120 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.